Analyst firms · Goldman Sachs · ALHC

Goldman Sachs ALHC price target and rating history

Alignment Healthcare Inc. (ALHC) · Health Care

Goldman Sachs rates Alignment Healthcare Inc. (ALHC) Buy with a $21 price target, as of its latest action on Oct 14, 2025. It has published 3 rating actions on ALHC since December 2021, including 0 upgrades and 0 downgrades.

Current rating
Buy
Price target
$21
Median target, all firms
Too few
Actions on ALHC
3

Goldman Sachs price target on ALHC

$21$19$1620222023202420252026
Goldman Sachs price target on ALHC, each point a stated target, December 2021 to October 2025.

Every Goldman Sachs rating on ALHC

How other firms rate ALHC

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
KeyBanc Capital MarketsSector WeightOct 30, 2026
NeedhamHoldOct 28, 2026
William BlairMkt PerformOct 9, 2026
Raymond JamesOutperform$19Aug 3, 2026
Wolfe ResearchOutperform$24Apr 17, 2026

Questions about Goldman Sachs and ALHC

What is Goldman Sachs's price target for ALHC?
Goldman Sachs's latest stated price target for Alignment Healthcare Inc. (ALHC) is $21, from its action on Oct 14, 2025.
What is Goldman Sachs's rating on ALHC?
Goldman Sachs rates ALHC Buy, a bullish rating, as of Oct 14, 2025.
When did Goldman Sachs last change its view on ALHC?
On Oct 14, 2025, Goldman Sachs starts coverage at Buy, price target $21.

More ALHC rating histories

All Goldman Sachs ratingsALHC news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.